Talphera Inc (TLPH) Stock Price, Quote & News

Company Profile

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acu...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 650 216 3500

Website: talphera.com

Address:

1850 Gateway Drive, Suite 175, San Mateo, United States

biotrade123 Aug. 3 at 4:27 PM

$TLPH is this being shorted? although the short interest looks quite low at 2.3%??

0 · Reply

CaliEmpress Jul. 30 at 10:48 PM

$TLPH

2 · Reply

Crandaddy01 Jul. 30 at 2:18 PM

$TLPH

0 · Reply

KUMO2026 Jul. 28 at 12:05 PM

$TLPH ready to drop hard and fast off the algo trap

1 · Reply

Yoda896 Jul. 28 at 11:37 AM

$TLPH Two possible scenarios in August CC: 1) They don't tell us how many have been enrolled, but they tell us that enrollment is going great, we will be done before the end of this year. 2) They tell us if the rate of enrollment this year remains the same, we will be done before the end of this year. Reaction to 1: We go down close to $1, possibly lower. Reaction to 2: We go up higher than $1.50, possibly $2

1 · Reply

BigTpain Jul. 26 at 2:05 AM

$TLPH we've been over this.... STFU

0 · Reply

KUMO2026 Jul. 24 at 2:14 PM

$TLPH took another short off 1.43 algo trap

1 · Reply

nazzangr Jul. 24 at 1:53 PM

$TLPH what happened to that chart analyst guy. There was a gap up from yesterday close to todays opening. Analyze that for me please

0 · Reply

Yoda896 Jul. 24 at 12:01 PM

$TLPH My guess for the rise yesterday (and today), in order of likelihood: * Institutions that buy only when a stock is over $1, realized that they must buy some shares in anticipation of good Niyad results. They needed time to go through the bureaucracy before they made the decision. * Investors and traders felt it's time to buy, even if they had to pay higher prices. * A new analyst recommendation sent only to their clients. The clients are given a few days to buy before the news is published. * Traders felt that they accumulated enough at the lowest prices they could get, and it's time for them to unload. So, they jack it up, and then sell.

1 · Reply

biotrade123 Jul. 24 at 12:06 AM

$TLPH Significantly high AH vol of 13k??

0 · Reply

Talphera Transcript: AGM 2026

2026-06-05T10:27:07.000Z - 2 months ago

Talphera assumed with a Buy at H.C. Wainwright

2026-05-13T21:03:38.000Z - 2 months ago

Talphera reports Q1 EPS (4c) vs. (10c) last year

May 13, 2026, 4:30 PM EDT - 2 months ago

Talphera Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

Talphera Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

Talphera Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 2 months ago

Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update

May 7, 2026, 4:05 PM EDT - 3 months ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026

2026-04-30T18:25:47.000Z - 3 months ago

Talphera initiated with a Buy at WestPark Capital

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Talphera Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Talphera Proxy statement: Proxy filing

Apr 9, 2026, 7:00 AM EDT - 4 months ago

Talphera Slides: Corporate presentation

Mar 25, 2026, 8:30 AM EDT - 4 months ago

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026

Mar 25, 2026, 8:00 AM EDT - 4 months ago

Talphera Registration statement: Registration filing

2026-03-25T10:05:29.000Z - 4 months ago

Talphera files to sell 639,931 shares of common stock for holders

Mar 23, 2026, 11:00 AM EDT - 4 months ago

Talphera Earnings Call Transcript: Q4 2025

Mar 23, 2026, 11:00 AM EDT - 4 months ago

Talphera Annual report: Q4 2025

Mar 23, 2026, 11:00 AM EDT - 4 months ago

Talphera Earnings release: Q4 2025

2026-03-23T12:41:43.000Z - 4 months ago

Talphera reports Q4 EPS (6c) vs. (7c) last year

Mar 23, 2026, 8:30 AM EDT - 4 months ago

Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Mar 18, 2026, 4:05 PM EDT - 4 months ago

Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

2026-03-02T13:48:08.000Z - 5 months ago

Talphera announces 50% patient enrollment of the NEPHRO-CRRT clinical trial

Mar 2, 2026, 8:30 AM EST - 5 months ago

Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial

Nov 12, 2025, 4:30 PM EST - 9 months ago

Talphera Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

Talphera Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

Talphera Earnings release: Q3 2025

2025-11-12T21:23:13.000Z - 9 months ago

Talphera reports Q3 EPS (11c) vs. (13c) last year

Nov 12, 2025, 4:05 PM EST - 9 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

CRMD

Nov 5, 2025, 4:05 PM EST - 9 months ago

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

2025-10-28T20:36:26.000Z - 9 months ago

Talphera files to sell 1.02M shares of common stock for holders

Oct 28, 2025, 8:00 AM EDT - 10 months ago

Talphera Registration statement: Registration Filing

Oct 21, 2025, 8:30 AM EDT - 10 months ago

Talphera Announces the Appointment of Joe Todisco to Board of Directors

2025-09-22T21:15:15.000Z - 11 months ago

Talphera files to sell 25.04M shares of common stock for holders

Sep 22, 2025, 8:00 AM EDT - 11 months ago

Talphera Registration statement: Registration Filing

Sep 9, 2025, 8:00 AM EDT - 11 months ago

Talphera Proxy statement: Proxy Filing

Sep 9, 2025, 8:00 AM EDT - 11 months ago

Talphera Proxy statement: Proxy Filing

2025-09-08T12:45:47.000Z - 11 months ago

CorMedix makes $5M minority equity investment in Talphera

CRMD

Sep 8, 2025, 8:30 AM EDT - 11 months ago

CorMedix Announces Strategic Minority Investment in Talphera

CRMD

Sep 8, 2025, 8:30 AM EDT - 11 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

CRMD

Aug 29, 2025, 8:00 AM EDT - 1 year ago

Talphera Proxy statement: Proxy Filing

2025-08-25T12:35:24.000Z - 1 year ago

Talphera enrolls 17 patients in 70-patient pivotal NEPHRO CRRT clinical trial

Aug 25, 2025, 8:30 AM EDT - 1 year ago

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings release: Q2 2025

2025-08-14T20:16:22.000Z - 1 year ago

Talphera reports Q2 EPS (10c) vs. (15c) last year

2025-08-14T20:16:01.000Z - 1 year ago

Talphera lowers 2025 cash operating expense view to $16M-$17M from $17M-$19M

Aug 14, 2025, 4:05 PM EDT - 1 year ago

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 7, 2025, 4:35 PM EDT - 1 year ago

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings release: Q1 2025

2025-05-14T20:17:58.000Z - 1 year ago

Talphera reports Q1 EPS (10c), consensus (14c)

2025-05-14T20:17:33.000Z - 1 year ago

Talphera sees 2025 expenses $17M-$19M

May 14, 2025, 4:05 PM EDT - 1 year ago

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 7, 2025, 4:05 PM EDT - 1 year ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

2025-05-02T21:20:14.000Z - 1 year ago

Talphera files to sell 3.41M shares of common stock for holders

May 2, 2025, 8:00 AM EDT - 1 year ago

Talphera Registration statement: Registration Filing

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Talphera Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Talphera Earnings release: Q4 2024

2025-03-31T20:11:33.000Z - 1 year ago

Talphera reports Q4 EPS (7c) vs. (25c) last year

Mar 31, 2025, 4:05 PM EDT - 1 year ago

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

2025-03-31T12:40:30.000Z - 1 year ago

Talphera announces agreement with FDA to reduce NEPHRO CRRT study size

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Mar 26, 2025, 4:38 PM EDT - 1 year ago

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Jan 14, 2025, 8:30 AM EST - 1 year ago

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Nov 13, 2024, 4:30 PM EST - 1 year ago

Talphera Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Talphera Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Talphera Earnings release: Q3 2024

Nov 13, 2024, 4:05 PM EST - 1 year ago

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6, 2024, 4:05 PM EST - 1 year ago

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Oct 16, 2024, 3:00 PM EDT - 1 year ago

Talphera Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 8, 2024, 4:54 PM EDT - 1 year ago

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Sep 5, 2024, 4:15 PM EDT - 2 years ago

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 19, 2024, 8:30 AM EDT - 2 years ago

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings release: Q2 2024

Aug 14, 2024, 4:01 PM EDT - 2 years ago

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 5, 2024, 4:05 PM EDT - 2 years ago

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

May 20, 2024, 5:25 PM EDT - 2 years ago

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 16, 2024, 5:45 PM EDT - 2 years ago

Talphera to Participate at A.G.P. Virtual Healthcare Conference

May 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings Call Transcript: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Quarterly report: Q1 2024

May 14, 2024, 4:30 PM EDT - 2 years ago

Talphera Earnings release: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 2, 2024, 4:15 PM EDT - 2 years ago

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Talphera Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Talphera Proxy statement: Proxy Filing

Mar 6, 2024, 4:30 PM EST - 2 years ago

Talphera Earnings Call Transcript: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

Talphera Annual report: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

Talphera Earnings release: Q4 2023

Mar 6, 2024, 4:05 PM EST - 2 years ago

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Mar 1, 2024, 7:30 AM EST - 2 years ago

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Feb 26, 2024, 4:15 PM EST - 2 years ago

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Feb 6, 2024, 7:00 AM EST - 2 years ago

Talphera Registration statement: Registration Filing

Jan 18, 2024, 8:30 AM EST - 2 years ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

biotrade123 Aug. 3 at 4:27 PM

$TLPH is this being shorted? although the short interest looks quite low at 2.3%??

0 · Reply

CaliEmpress Jul. 30 at 10:48 PM

$TLPH

2 · Reply

Crandaddy01 Jul. 30 at 2:18 PM

$TLPH

0 · Reply

KUMO2026 Jul. 28 at 12:05 PM

$TLPH ready to drop hard and fast off the algo trap

1 · Reply

Yoda896 Jul. 28 at 11:37 AM

1 · Reply

BigTpain Jul. 26 at 2:05 AM

$TLPH we've been over this.... STFU

0 · Reply

KUMO2026 Jul. 24 at 2:14 PM

$TLPH took another short off 1.43 algo trap

1 · Reply

nazzangr Jul. 24 at 1:53 PM

$TLPH what happened to that chart analyst guy. There was a gap up from yesterday close to todays opening. Analyze that for me please

0 · Reply

Yoda896 Jul. 24 at 12:01 PM

1 · Reply

biotrade123 Jul. 24 at 12:06 AM

$TLPH Significantly high AH vol of 13k??

0 · Reply

AlwaysRational Jul. 23 at 8:04 PM

$TLPH Today's move makes it appear that an ascending stair step pattern is in effect. Good news if that's the case.

0 · Reply

MartinDavies99 Jul. 23 at 5:51 PM

$TLPH I’m bullish as every day we are getting closer to completion of P3 for Niyad that is already well established and successful in other countries. That should have a very quick turnaround to release of data, approval and commercial rollout. I am hoping that although CorMedix will have 60 priority other companies will make approaches that will enable the board to push the price up to over $3, as it has much greater potential in a larger organisation. IMO we will see a BO within a year but that’s NIA. Brave hearts have to hold firm.❤️🤞🌈💥🚀

1 · Reply

Tozbaki Jul. 20 at 2:49 PM

$TLPH What are the cataylsts here?

1 · Reply

Estimize Jul. 20 at 1:01 PM

Wall St is expecting -0.06 EPS for $TLPH Q2 [Reporting 08/19 AMC] http://www.estimize.com/intro/tlph?chart=historical&metric_name=eps&utm_c

0 · Reply

Yoda896 Jul. 18 at 2:12 PM

$TLPH I badly want to listen to you. I'm just worried in case you were one of them GD phools.

0 · Reply

Yoda896 Jul. 18 at 2:09 PM

$TLPH I honestly wish I knew. If I knew, I would short it with all my money. I don't because it could at any minute gap up over $3 or $4 or higher.

1 · Reply

firedupinvestors Jul. 17 at 6:37 PM

$TLPH is this going back undé $1.

0 · Reply

BigTpain Jul. 17 at 6:23 PM

$TLPH STFU

1 · Reply

KUMO2026 Jul. 17 at 6:16 PM

$TLPH free fall coming in fast

0 · Reply

KUMO2026 Jul. 17 at 5:59 PM

$TLPH Stock in trouble off algo trap 1.50 here comes 1.00

0 · Reply

KUMO2026 Jul. 16 at 4:03 PM

$TLPH algo trap again and now ready to drop hard and fast

3 · Reply

Crandaddy01 Jul. 16 at 3:39 PM

$TLPH

0 · Reply

Market Cap	66.43M
Revenue (ttm)	30,000.00
Net Income (ttm)	-14.29M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47,633.33%
Debt to Equity Ratio	0.00

Volume	120,400
Avg Vol	300,828
Day's Range	N/A - N/A
Shares Out	51.90M
Stochastic %K	52%
Beta	0.70
Analysts	Strong Sell
Price Target	$3.17